Repeat TURBT
Showing 1 - 25 of 2,293
Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Urothelial Carcinoma, High Risk Non-Muscle Invasive Bladder
Not yet recruiting
- Non-muscle-invasive Bladder Cancer
- +2 more
- PDD-TURBT with hexaminolevulinate (Hexvix®)
- Power Led Saphira (TM) from KARL STORZ
- (no location specified)
Jul 24, 2023
Bladder Cancer, Bladder Urothelial Carcinoma Trial in Toronto (re-TURBT, 6 weeks BCG instillation)
Terminated
- Bladder Cancer
- Bladder Urothelial Carcinoma
- re-TURBT
- 6 weeks BCG instillation
-
Toronto, Ontario, CanadaUniversity Health Network
Apr 12, 2022
Bladder Cancer Trial in Mansoura (Outpatient check cytoscopy, Urine cytology)
Recruiting
- Bladder Cancer
- Outpatient check cytoscopy
- Urine cytology
-
Mansoura, DK, EgyptMansoura Urology and Nephrology Center
Dec 21, 2021
Bladder Cancer Trial in Mansoura (Primary TURBT)
Completed
- Bladder Cancer
- Primary TURBT
-
Mansoura, DK, EgyptUrology and Nephrology Center
Oct 24, 2020
Can Second Resection for pT1 Bladder Cancer be Avoided After
Recruiting
- Bladder Cancer Stage I
- Avoid second resection after initial complete resection
-
Mansoura, Dakahlia, EgyptUrology and nephrology center, Mansoura University
Aug 2, 2023
Non Muscle Invasive Bladder Cancer, Urologic Cancer, Bladder Cancer Trial (Cretostimogene Grenadenorepvec,
Not yet recruiting
- Non Muscle Invasive Bladder Cancer
- +3 more
- Cretostimogene Grenadenorepvec
- n-dodecyl-B-D-maltoside
- (no location specified)
Oct 30, 2023
Bladder Cancer Trial (En bloc resection of bladder tumour)
Not yet recruiting
- Bladder Cancer
- En bloc resection of bladder tumour
- (no location specified)
Jun 24, 2022
Non-muscle Invasive Bladder Cancer (NMIBC) Trial in Rozzano (Hyaluronic Acid (HA) sodium salt and Hydeal-D)
Terminated
- Non-muscle Invasive Bladder Cancer (NMIBC)
- Hyaluronic Acid (HA) sodium salt and Hydeal-D
-
Rozzano, Mi, ItalyHumanitas Research Hospital
Sep 29, 2023
Bladder Cancer Trial in Hong Kong (Bipolar transurethral standard resection, Bipolar transurethral en bloc resection)
Completed
- Bladder Cancer
- Bipolar transurethral standard resection
- Bipolar transurethral en bloc resection
-
Hong Kong, Hong Kong
- +12 more
Jun 24, 2022
Bladder Urothelial Carcinoma, Bladder Cancer Trial in São Paulo (Monopolar Transurethral resection of bladder tumor, Holmium
Recruiting
- Bladder Urothelial Carcinoma
- Bladder Cancer
- Monopolar Transurethral resection of bladder tumor
- Holmium Laser resection of bladder tumor (HoLEBT)
-
São Paulo, BrazilInstituto do Cancer do Estado de São Paulo (ICESP)
Apr 18, 2023
Non-muscle-invasive Bladder Cancer Trial in Cairo (BCG, Gemcitabine)
Recruiting
- Non-muscle-invasive Bladder Cancer
-
Cairo, EgyptMohamed Fawzy Salman
Nov 19, 2022
Muscle-Invasive Bladder Carcinoma, Chemo Effect, Surgery Trial in Rome (cisplatin based neoadjuvant chemo, Radical cystectomy
Recruiting
- Muscle-Invasive Bladder Carcinoma
- +2 more
- cisplatin based neoadjuvant chemotherapy
- Radical cystectomy alone
-
Rome, ItalyRiccardo Mastroianni
Mar 8, 2023
Cystoscope, Bladder Cancer, Lower Urinary Tract Symptoms Trial in Herlev (Ambu aScope 4 Cysto and aView Urologia)
Completed
- Cystoscope
- +2 more
- Ambu aScope 4 Cysto and aView Urologia
-
Herlev, DenmarkHerlev Hospital
Oct 13, 2021
Muscle Invasive Bladder Cancer, Urothelial Carcinoma Trial in Tianjin (Tislelizumab, Nab paclitaxel)
Active, not recruiting
- Muscle Invasive Bladder Cancer
- Urothelial Carcinoma
- Tislelizumab
- Nab paclitaxel
-
Tianjin, Tianjin, ChinaTianjin Medical University Second Hospital
Nov 23, 2022
Urinary Bladder Tumors Trial run by the NCI (Durvalumab, Vicineum)
Recruiting
- Urinary Bladder Neoplasms
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Analyzing Urine During BCG Instillation in Bladder Cancer
Not yet recruiting
- Bladder Cancer
- urine sample collection
-
Shanghai, Shanghai, ChinaChanghai Hospital
Nov 30, 2023
Bladder Cancer Trial in Baltimore (ERAS Protocol, Standard of Care)
Not yet recruiting
- Bladder Cancer
- ERAS Protocol
- Standard of Care
-
Baltimore, MarylandJohns Hopkins Hospital
Jun 14, 2023
Intravesical BCG: is the Urinary Bladder Ready to Receive it
Not yet recruiting
- Non-Invasive Bladder Urothelial Carcinoma
- (no location specified)
Jun 7, 2022
Urothelial Carcinoma of the Bladder Trial in Washington, Baltimore, Philadelphia (drug, radiation, procedure)
Active, not recruiting
- Urothelial Carcinoma of the Bladder
- Methotrexate
- +7 more
-
Washington, District of Columbia
- +3 more
Dec 2, 2022
Bladder Cancer Trial in Netherlands (mpMRI plus a same-day cystoscopic bladder biopsy, TURBT)
Not yet recruiting
- Bladder Cancer
- mpMRI plus a same-day cystoscopic bladder biopsy
- TURBT
-
Almelo, Netherlands
- +11 more
Mar 23, 2023
Muscle Invasive Bladder Cancer Urothelial Carcinoma Trial in Tianjin (Tislelizumab Nab paclitaxel)
Recruiting
- Muscle Invasive Bladder Cancer Urothelial Carcinoma
- Tislelizumab Nab paclitaxel
-
Tianjin, Tianjin, Chinaianjin Medical University Second Hospital
Jun 8, 2022
Urothelial Carcinoma Trial in Miami, New Orleans, Rochester (MV-NIS)
Recruiting
- Urothelial Carcinoma
- MV-NIS
-
Miami, Florida
- +2 more
Jun 15, 2021
Bladder Tumor Trial in Yenimahalle (Interfascial Injection, Subpectineal Injection)
Not yet recruiting
- Bladder Neoplasm
- Interfascial Injection
- Subpectineal Injection
-
Yenimahalle, Ankara, TurkeyHealth Science University Diskapi Yildirim Beyazıt Training and
Sep 14, 2022
Bladder Cancer, Bladder Tumor Trial in Banha (Bipolar En bloc TURBT, Monopolar En bloc TURBT)
Recruiting
- Bladder Cancer
- Bladder Neoplasm
- Bipolar En bloc TURBT
- Monopolar En bloc TURBT
-
Banhā, Qalubia, EgyptBanha university hospital
Jul 17, 2022